Article
Allopregnanolone levels are reduced in temporal cortex in patients with Alzheimer's disease compared to cognitively intact control subjects.
Biochimica et biophysica acta - 1 Aug 2010
Naylor Jennifer C, Kilts Jason D, Hulette Christine M, Steffens David C, Blazer Dan G, Ervin John F, Strauss Jennifer L, Allen Trina B, Massing Mark W, Payne Victoria M, Youssef Nagy A, Shampine Lawrence J, Marx Christine E
Abstract excerpt
The neurosteroid allopregnanolone has pronounced neuroprotective actions, increases myelination, and enhances neurogenesis. Evidence suggests that allopregnanolone dysregulation may play a role in the pathophysiology of Alzheimer's disease (AD) and other neurodegenerative disorders. Our prior dat...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
